Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On11 Nov 2025
Close On13 Nov 2025
Price Range₹200-204
Testimonial
Genuine Review Form Statisifed Customers
KSquare delivers excellent service and fund recommendations. The platform makes investing feel less like a chore and more like a plan I’m excited to follow.
I was impressed by how seamless KSquare’s NRI services are. They handled my documentation with care and helped me invest without unnecessary hassle.
KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.
I’ve used a few platforms before, but KSquare is easily the most user-centric. Their mutual fund tools make planning easy and returns trackable.
Starting SIPs with KSquare has brought so much clarity to my finances. Their platform is smooth, and the investment returns speak for themselves.
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
KSquare helped me reconnect financially with India. Their NRI services are intuitive, quick, and focused on individual needs. Truly impressed!
Investing in NPS with KSquare has given me great peace of mind. Their platform is user-friendly and informative for long-term goals.
I started SIPs with KSquare six months ago and already see consistent growth. Their timely updates and reports make tracking easy. Definitely a smart decision for financial planning.
Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.
FAQ's
Frequenlty Asked Question
Do I need a demat account to apply for this loan?
Yes, most lenders require mutual fund units in demat form. KSquare can help convert physical units if needed.
Can I nominate someone for my NPS account?
Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.
Are SIP investments safe?
While SIPs are subject to market risks, long-term investing and diversification help reduce risk and improve returns.
Can I cancel or modify my NFO investment once submitted?
No, once submitted during the NFO period, investments cannot be modified or canceled. KSquare recommends careful planning.
Is there a credit score requirement for getting LAMF?
While credit score matters, lenders also consider the value and type of mutual funds pledged. KSquare helps assess your eligibility beforehand.
Is there a lock-in period for mutual fund investments?
Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.
How much loan can I get against mutual funds?
You can typically borrow up to 50–70% of your mutual fund’s NAV value. KSquare calculates this during your application.
What is the role of the AMC in a New Fund Offering?
The Asset Management Company (AMC) designs and manages the NFO, ensuring strategy alignment and regulatory compliance.